Effects of light-activated diazido-PtIV complexes on cancer cells in vitro

Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences

Volumn 371, Issue 1995, 2013, Pages

  Bednarski, Patrick J ^a   Korpis, Katharina ^a   F Westendorf, Aron ^a   Perfahl, Steffi ^a   Grünert, Renate ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Apoptosis; Autophagy; Cancer; Cisplatin; Photoactivation, platinum diazides

Indexed keywords

BIOMOLECULES; CELL DEATH; CELL PROLIFERATION; CHEMICAL COMPOUNDS; CHLORINE COMPOUNDS; COORDINATION REACTIONS; DISEASES; DNA; PHOTOLYSIS; PLATINUM; THYMUS;

ANTI-CANCER AGENTS; AUTOPHAGY; CANCER; CIS-PLATIN; COORDINATION GEOMETRY; PHOTO ACTIVATIONS; PHOTOLYSIS PRODUCTS; REACTIVE OXYGEN SPECIES;

PLATINUM COMPOUNDS;

ANTINEOPLASTIC AGENT; AZIDE; CISPLATIN; PHOTOSENSITIZING AGENT; PLATINUM;

ANIMAL; APOPTOSIS; AUTOPHAGY; HUMAN; LIGHT; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOACTIVATION; PHOTOCHEMOTHERAPY; PLATINUM DIAZIDES; REVIEW;

APOPTOSIS; AUTOPHAGY; CANCER; CISPLATIN; PHOTOACTIVATION; PLATINUM DIAZIDES;

ANIMALS; ANTINEOPLASTIC AGENTS; AZIDES; HUMANS; LIGHT; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLATINUM;

EID: 84887400140     PISSN: 1364503X     EISSN: None     Source Type: Journal    
DOI: 10.1098/rsta.2012.0118     Document Type: Review

References (44)

1. Ducry L, Stump B. 2010 Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies. Bioconjug. Chem. 21, 5-13. (doi:10.1021/bc9002019)
2. Bagshawe KD. 2007 Antibody-directed enzyme prodrug therapy. In Prodrugs: challenges and rewards, part II (eds VJ Stella, RT Borchardt, MJ Hageman, R Oliyai, H Maag, JW Tilley), pp. 525-540. New York, NY: Springer.
3. Harrington KJ, Vile RG, Pandha HS, Schepelmann S, Hedley D, Ogilvie LM, Springer CJ. 2008 Gene-directed enzyme prodrug therapy. In Viral therapy of cancer (eds KJ Harrington, RG Vile, HS Pandha), ch. 16, pp. 255-276. Chichester, UK: John Wiley & Sons. (doi:10.1002/9780470985793.ch16)
4. Low PS, Henne WA, Doorneweerd DD. 2007 Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120-129. (doi:10.1021/ar7000815)
5. Ulbrich K, Subr V. 2004 Polymeric anticancer drugs with pH-controlled activation. Adv. Drug Deliv. Rev. 56, 1023-1050. (doi:10.1016/j.addr.2003.10. 040) (Pubitemid 38520207)
6. Farrer NJ, Salassa L, Sadler PJ. 2009 Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine. Dalton Trans. 48, 10 690-10 701. (doi:10.1039/B917753A)
7. Bednarski PJ, Mackay FS, Sadler PJ. 2007 Photoactivatable platinum complexes. Anti-Cancer Agents Med. Chem. 7, 75-93. (doi:10.2174/ 187152007779314053) (Pubitemid 46062406)
8. Hamberger J, Liebeke M, Kaiser M, Bracht K, Olszewski U, Zeillinger R,Hamilton G, Braun D, Bednarski PJ. 2009 Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents. Anti-Cancer Drugs 20, 559-572. (doi:10.1097/CAD. 0b013e32832d513b)
9. Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM. 2007 Biochemical mechanisms of cisplatin cytotoxicity. Anti-Cancer Agents Med. Chem. 7, 3-18. (doi:10.2174/187 152007779314044) (Pubitemid 46062402)
10. Kelland L. 1993 New platinum antitumor complexes. Crit. Rev. Oncol. Hematol. 15, 191-219. (doi:10.1016/1040-8428(93)90042-3) (Pubitemid 24047767)
11. Kratochwil NA, Bednarski PJ, Mrozek H, Vogler A, Nagle JK. 1996 Photolysis of an iodoplatinum(IV) diamine complex to cytotoxic species by visible light. Anti-Cancer Drug Design 11, 155-171. (Pubitemid 26145472)
12. Kratochwil NA, Zabel M, Range KJ, Bednarski PJ. 1996 Synthesis and X-ray crystal structure of trans,cis[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro. J. Med. Chem. 39, 2499-2507. (doi:10.1021/jm9509105) (Pubitemid 26199140)
13. Müller P, Schröder B, Parkinson JA, Kratochwil NA, Coxall RA, Parkin A, Parsons S, Sadler PJ. 2003 Nucleotide cross-linking induced by photoreactions of platinum(IV)-azide complexes. Angew. Chem. Int. Ed. 115, 349-353. (doi:10.1002/anie.200390110) (Pubitemid 36176319)
14. Vogler A, Kern A, Hüttermann J. 1978 Photochemical reductive trans-elimination from transdiazidotetracyanoplatinate( IV) complexes. Angew. Chem. Int. Ed. 17, 524-525. (doi:10.1002/anie.197805241)
15. Vogler A, Wright RE, Kunkely H. 1980 Photochemical reductive cis-elimination in cis-diazidobis(triphenylphosphane)platinum(II): evidence of the formation of bis(triphenylphosphane) platinum(0) and hexaazabenzene. Angew. Chem. Int. Ed. 19, 717-718. (doi:10.1002/anie.198007171)
16. Vogler A, Hlavatsch J. 1983 Photochemical four-electron redox reaction of hexaazidoplatinate( IV). Angew. Chem. Int. Ed. 22, 154-155. (doi:10.1002/anie.198301542)
17. Mackay FS, Woods JA, Moseley H, Ferguson J, Dawson A, Parsons S, Sadler PJ. 2006 A photoactivated trans-diammine complex as cytotoxic as cisplatin. Chem. Eur. J. 12, 3155-3161. (doi:10.1002/chem.200501601)
18. Mackay FS, Woods JA, Heringova P, Kasparkova J, Pizarro AM, Moggach SA, Parsons S, Brabec V, Sadler PJ. 2007 A potent cytotoxic photoactivated platinum complex. Proc. Natl Acad. Sci. USA 104, 20 743-20 748. (doi:10.1073/pnas. 0707742105)
19. Westendorf AF, Bodtke A, Bednarski PJ. 2011 Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo- Pt(IV) complexes. Dalton Trans. 40, 5342-5351. (doi:10.1039/C0DT01485K)
20. Mackay FS, Moggach SA, Collins A, Parsons S, Sadler PJ. 2009 Photoactive trans ammine/amine diazido platinum(IV) complexes. Inorg. Chim. Acta 362, 811-819. (doi:10.1016/j.ica.2008.02.039)
21. Ronconi L, Sadler PJ. 2008 Unprecedented carbon-carbon bond formation induced by photoactivation of a platinum(IV)-diazido complex. Chem. Commun. 235-237. (doi:10.1039/b714216a) (Pubitemid 350294108)
22. Ronconi L, Sadler PJ. 2011 Photoreaction pathways for the anticancer complex trans,trans,trans-[Pt(N3)2(OH)2(NH3)2]. Dalton Trans. 262-268. (doi:10.1039/c0dt00546k)
23. Westendorf AF et al. 2013 Trans, trans, trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light activated antitumor platinum complex that kills human cancer cells by an apoptosis independent mechanism. Mol. Cancer Ther. 11, 1894-1904. (doi:10.1158/1535-7163.MCT-11-0959)
24. Bednarski PJ, Grünert R, Zielzki M,Wellner A, Mackay F, Sadler PJ. 2006 Light-activated destruction of cancer cell nuclei by platinum diazide comlexes. Chem. Biol. 13, 61-67. (doi:10.1016/j.chembiol.2005.10.011) (Pubitemid 43099925)
25. Westendorf AF. 2012 Synthese und Charakterisierung von photoaktivierbaren trans-Pt(IV)-Diaziden und Evaluierung iher DNA-bindenden und antiproliferativerenden Eigenschaften an Krebszellen unter Einfluss von Licht. Dissertation, University of Greifswald, Germany.
26. Salassa L, Phillips HIA, Sadler PJ. 2009 Decomposition pathways for the photoactivated anticancer clomplex cis,trans,cis-[Pt(N3)2(OH)2(NH3)2]: insights from DFT calculations. Phys. Chem. Chem. Phys. 11, 10 311-10 316. (doi:10.1039/b912496a)
27. Farrer NJ,Woods JA, Salassa L, Zhao Y, Robinson KS, Clarkson G, Mackay FS, Sadler PJ. 2010 A potent trans-diimine platinum anticancer complex photoactivated by visible light. Angew. Chem. Int. Ed. 49, 8905-8908. (doi:10.1002/anie.201003399)
28. Westendorf AF, Zerzankova L, Salassa L, Sadler PJ, Brabec V, Bednarski PJ. 2011 Influence of pyridine versus piperidine ligands on the chemical, DNA binding and cytotoxic properties of light activated trans,trans,trans-[Pt(N3) 2(OH)2(NH3)(L)]. J. Inorg. Biochem. 105, 652-662. (doi:10.1016/j.jinorgbio.2011. 01.003)
29. Sokolov AY, Schaefer HF. 2011 Ground and excited state properties of photoactive platinum(IV) diazido complexes: theoretical considerations. Dalton Trans. 40, 7571-7582. (doi:10.1039/c1dt10493d)
30. Kratochwil KA, Parkinson JA, Bednarski PJ, Sadler PJ. 1999 Nucleotide platination induced by visible light. Angew. Chem. Int. Ed. 38, 1460-1463. (doi:10.1002/(SICI)1521-3773 (19990517)38:103.0.CO;2-Z) (Pubitemid 29242103)
31. Kasparkova J, Mackay FS, Brabac V, Sadler PJ. 2003 Formation of platinated GG cross-links on DNA by photactivation of a platinum(IV) azide complex. J. Biol. Inorg. Chem. 8, 741-745. (doi:10.1007/s00775-003-0474-3) (Pubitemid 37203952)
32. Pracharova J, Zerzankova L, Stepankova J, Novakova O, Farrer NJ, Sadler PJ, Brabec V, Kasparkova J. 2012 Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells. Chem. Res. Toxicol. 25, 1099-1111. (doi:10.1021/ tx3000057y)
33. Kratochwil NA, Guo Z, del Socorro Murdoch P, Parkinson JA, Bednarski PJ, Sadler PJ. 1998 Electron-transfer-driven trans-ligand labilization: a novel activation mechanism for Pt(IV) anticancer complexes. J. Am. Chem. Soc. 120, 8253-8254. (doi:10.1021/ja980393q) (Pubitemid 28417642)
34. Farrer NJ, Woods JA, Munk VP, Mackay FS, Sadler PJ. 2010 Photocytotoxic trans-diam(m)ine plaitnum(IV) diazido comlexes more potent than their cis isomers. Chem. Res. Toxicol. 23, 413-421. (doi:10.1021/tx900372p)
35. Bracht K, Boubakari , Grünert R, Bednarski PJ. 2006 Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data. Anti-Cancer Drugs 17, 41-51. (doi:10.1097/01.cad.0000190280.60005.05)
36. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. 1983 Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130, 1910-1917. (Pubitemid 13091657)
37. Majno G, Joris I. 1995 Apoptosis, oncosis, and necrosis: an overview of cell-death. Am. J. Pathol. 146, 3-15.
38. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. 1995 Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184, 39-51. (doi:10.1016/0022-1759(95)00072-I)
39. Tooze SA. 2012 Emerging details shed light on mammalian autophagy. Biochemist 34, 4-7.
40. Korolchuk VI, Rubinsztein DC. 2012 On signals controlling autophagy. Biochemist 34, 8-13.
41. Klionsky DJ et al. 2008 Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151-175. (doi:10.4161/auto.19496) (Pubitemid 351231180)
42. Mizushima N, Yoshimori T. 2007 How to interpret LC3 immunoblotting Autophagy 3, 542-545. (Pubitemid 350060049)
43. Doane TL, Burda C. 2012 The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem. Soc. Rev. 41, 2885-2911. (doi:10.1039/c2cs15260f).
44. Garcia JV, Zhang F, Ford PC. 2013 Multi-photon excitation in uncaging the small molecule bioregulator nitric oxide. Phil. Trans. R. Soc. A 371, 20120129. (doi:10.1098/rsta.2012.0129)